The aspartase gene (aspA) of Escherichiu coli has been isolated in two plasmids, pGS73 and pGS94, which contain segments of bacterial DNA (12.5 and 2.8 kb, respectively) inserted into the tet gene of the vector pBR322. The plasmids were constructed by sequential sub-cloning from a larger ColE1-frd+ hybrid plasmid. The location of the aspA gene confirmed predictions based on a correlation between the genetic and restriction maps of the corresponding region. The aspartase activities of plasmid-containing aspA mutants were amplified four-to sixfold relative to aspA+ parental strains. The aspA gene product was tentatively identified as a polypeptide of M , 55 000, which is somewhat larger than previous estimates ( M , 45 000 to 48 000) for aspartase.
INTRODUCTION
Aspartase (L-aspartate ammonia-lyase, EC 4.3.1.1) catalyses the reversible conversion of Laspartate to fumarate and ammonia. The enzyme has been isolated from Escherichia coli strains B and W ; it has a molecular weight of 170000 to 193 000 and comprises four apparently identical subunits (Rudolph & Fromm, 1971; Suzuki et al., 1973) .
In E. coli aspartase participates in at least two metabolic processes: the regeneration of oxaloacetate as amino-acceptor for enabling growth on glutamate, and the formation of fumarate and succinate during anaerobic growth on glucose. The catabolism of glutamate involves transamination with oxaloacetate and oxidation of the resultant 2-oxoglutarate via the Krebs cycle. The oxaloacetate that serves as the primary amino-acceptor is converted to aspartate and then regenerated by a 'deamination cycle' involving aspartase, fumarase and malate dehydrogenase. Thus, aspA and aspC mutants lacking either aspartase or aspartate aminotransferase are unable to grow on glutamate as the sole source of carbon and energy (Marcus & Halpern, 1969~) . The importance of aspartate aminotransferase plus aspartase as an alternative route from oxaloacetate to fumarate and succinate during glucose fermentation was discovered in studies with malate dehydrogenase mutants and this role was supported by the observation that malate dehydrogenase is repressed whereas aspartase is derepressed during anaerobic growth (Courtright & Henning, 1970) .
The aspartase gene (aspA) has been located at 94.1 min in the E. coli linkage map by transduction when phage P1 (Spencer et al., 1976; Guest & Nice, 1978; Bachmann, 1983) . It lies between me/ and mop (groE), very close to mop (90 % cotransduction) and quite close to ampCA (71 % cotransduction) and frdA (67 % cotransduction), the gene order being: mel-uspAmop(groE)-ampCA-frdDCBA. Several segments of this region of the chromosome have been isolated in phages and plasmid vectors. These include the artificially-constructed R transducing phages, AgroE (Georgopoulos & Hohn, 1978; Hendrix & Tsui, 1978) , RfrdA and derivatives of AfrdA having extended transducing ranges, Afrd amp and Afrd amp groE (Cole & Guest, 1980a) , and the CoIEl-amp+frd+ hybrid plasmids isolated from the gene bank of Clarke & Carbon (1976) : pNUl (Edlund et al., 1979) , which is probably identical to pGSl and pLC16-43 (Guest, 1981) ; and pLC43-46 (Lohmeier et al., 1981) . Studies with these phages and plasmids have provided a restriction map for the corresponding 25kb segment of bacterial DNA and the
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positions of the mop(groE), amp and frd genes have been defined by selective labelling in transcription-translation systems and by nucleotide sequence analysis (Tilly et al., 1981 ; Cole & Guest, 1980b; Neidhardt et al., 1983) . A diagram correlating the genetic and restriction maps is presented in Fig. 1 , and it indicates that the aspA gene should lie within the region of DNA that has been cloned. This paper reports the location, isolation and expression of the aspA gene of E. coli.
METHODS
Bacterial strains. The strains of E. coli K12 are listed in Table 1 . The aspartase mutation (designated aspA23) came from CS8ASP/23, a mutant of a glutamate-permease-constitutive strain (CS8, gltC8) that was originally isolated by Marcus & Halpern (1969b) . A series of derivatives of W3110 and Ymel (W/G and W/Gasp, and Y/G and Y/Gasp) containing the gltC and aspA mutations were later constructed by PI transduction (Spencer et al., 1976) . For the work to be described, the aspA mutants were cured by replacing the P1 prophage with a temperature-inducible prophage (PlcmlclrIOO), and then isolating heat-resistant P1-sensitive derivatives. Recombination deficient strains were isolated by screening TetR transductants obtained with a P1 lysate prepared on an srl: :TnIOrecA mutant (Kleckner et al., 1977) .
Strains containing the ColEl-frd + hybrid plasmids, pLC16-43 and pLC43-46 (Edlundet al., 1979; Guest, 1981 ; Lohmeier et al., 1981) in JA200 were obtained from a copy of the Clarke & Carbon (1976) colony bank kindly provided by Dr R. A. Cooper. Strain C600 was used for routine phage preparation and assay, and its recA AR derivative (JRGl370) was used as the transformation recipient for plasmid construction. Other strains used for special purposes were: AB2480, the 'maxicell' host, and GM242, the host for producing plasmid DNA that is susceptible to BclI digestion.
Bacteriophages.
Populations of recombinant A phages containing Hind111 and EcoRI fragments of E. coli DNA in appropriate vectors (LNM540,ANM761,1781 and A816) were kindly provided by Dr N. E. Murray or prepared according to Borck et al. (1976) . The AfrdA phages, LGIF and LG40F, have been described previously (Cole & Guest, 1980a) as have the AgroE phages, AW3 and AH13a (Georgopoulos & Hohn, 1978) , which were kindly provided by Dr C. Georgopoulos.
Media.
The minimal medium E of Vogel & Bonner (1956) was used with glucose (1 1 mM) or monosodium Lglutamate (30 mM) as substrates. The medium was supplemented to satisfy the requirements of specific auxotrophs and sometimes enriched with Difco Bacto nutrient broth (0.2%, w/v). The complete media used for routine growth and maintenance were L and LG broth, and BBL medium was used for assaying L phages (Guest et al., 1983) : these were supplemented with the antibiotics, ampicillin (50 pg r n l -l ) , tetracycline (20 pg ml-I) or chloramphenicol (25 pg ml-I), as required for selective purposes. Media were solidified with Difco Bacto agar at 15, 10 or Genetic methods. The transduction procedures used for phage (Cole & Guest, 1980a) and phage P1 (Spencer et al., 1976) have been described previously.
Isolation and manipulation of DNA. The methods used for isolating phage and plasmid DNA have been described previously as have the methods for restriction endonuclease digestion, agarose gel electrophoresis and DNA ligation (Guest et al., 1983 Genotype or derivation gltC8 aspA23 trpR iclR (Pl); formerly W/Gasp gltC8 trpR iclR (Pl); formerly W/G gltC8 aspA23 supE57 supF58 (Pl); formerly Y/Gasp gltC8 supE57 supF58 (Pl); formerly Y/G P1-sensitive derivative of JRG821 P1-sensitive derivative of JRG817 srl : : Tn I0 recA derivative of JRG 1 1 14 srl: :TnIO recA derivative of J R G l l l 3 F+ , thr-I leuB6 trpE63 thi-I ara-I4 lac YI galK2 galT22 xyl-5 mtl-I supE44 (gln V44) thr-I leuB6 thi-I supE44 tonA2I lacYI thr-I leuB6 thi-I supE44 tonA2I lacYI recA LR F-, dam-3 recA I sin-2 thr-I leuB6proA2 his-4 metBI lac YI galK2 ara-I4 tsx-33phi-I deoB6 supE44 rpsL260 uvrA6 recAI3 pro-2 thi-I lac rpsL 'Maxicell' procedure. Polypeptides expressed from plasmid-encoded genes were labelled by the 'maxicell' technique of Sancar et al. (1979) details of which have been described previously by Shaw & Guest (1982) .
Enzymology. Cultures were grown in LG broth (250 ml in shaken 2 1 flasks) for 12 h at 37 "C, starting with an exponential culture (5 ml) grown in the same medium. In order to limit the segregation of plasmid-free bacteria, relatively large inocula were used and D-ampicillin (100 pg ml-l) was added, where possible. Cultures of mutant strains were also tested to ensure that significant reversion had not occurred. Ultrasonic extracts were prepared, dialysed against potassium phosphate buffer (0-04 M, pH 7.8), and assayed for protein according to Creaghan & Guest (1977) . Aspartase (L-aspartate ammonia lyase, EC 4.3.1.1) was assayed at 20 "C by estimating the rate of ammonia produced from aspartate over periods of 5 to 30 min with a range of protein concentrations and several different extracts, according to Spencer et al. (1976) . The specific activities are quoted in terms of pmol NH3 released (mg protein)-' h-' at 20°C.
Materials. Restriction enzymes were purchased from the Boehringer, BRL and New England Biolabs. T4 DNA ligase was from BRL and ~-[~~S]methionine (80 to 125 pCi m1-I; 2.96 to 4.625 MBq ml-l) was purchased from Amersham.
RESULTS

Location and isolation of the aspA gene
The results of genetic studies with aspartase mutants of E. coli are summarized in Fig. 1 . They indicate that the aspA gene should lie within 10 to 15 kb of the fumarate reductase genes (frdABCD) and quite close to the mop (groE) genes. These studies were hampered by having to Genetic and restriction maps of the mel-frd (94 min) region of the E. coli chromosome. The genetic map (a) is drawn to scale from phage P1 cotransduction frequencies for different pairs of markers (Spencer et al., 1976; Guest & Nice, 1978) ; the map distances are shown in kb, derived from the cotransduction frequencies according to Wu (1966) . The ampAZ and frdA markers have been used as fixed points for constructing the map, and the results indicate that the aspartase gene (aspA) is located very close to mop in the mel-mop segment. The ampAl marker is an up-promoter mutation of chromo- rely on the glutamate-utilizing phenotype (Glt +/Glt-) for diagnosing the aspA genotypes of recombinants. The problems stem from the fact that E. coli K12 will not normally grow on glutamate because glutamate transport is severely repressed. This necessitates the use of strains that express the transport system constitutively. These strains have mutations in the operator locus (gltC) that is adjacent to the glutamate permease structural gene (gltS) and they render permease synthesis insensitive to the gZtR-encoded repressor (Marcus & Halpern, 1969~) . It is also observed that aspA mutants exhibit a pronounced tendency to revert on glutamate medium. Consequently, the aspA marker is best used non-selectively and it is important to monitor for reversion at all stages. The same problems apply when devising strategies to clone the aspA gene by complementation.
The first attempts to isolate the aspA gene involved screening pools of hybrid A phages from aspA transducing phages using glutamate medium for selective purposes. Some evidence for aspA transduction was obtained but phages capable of complementing the aspA lesion were not found, suggesting that the intact and functional aspA gene is not released in fragments that can be accepted by the lambda vectors, viz: HindIII and EcoRI fragments ranging up to 16 kb. Transduction tests with previously characterized phages were either negative (Lfrd) or inconclusive ( AgroE).
Attempts to isolate the aspA gene by sub-cloning fragments of DNA from phages and plasmids containing the neighbouring mop (groE), amp and frd genes were more successful. These sources are illustrated in Fig. 1 , and they include the ColEl-frd+ plasmids, pLC16-43 and pLC43-46 as well as several transducing phages, h o p (groE) and Afrd. A basic restriction map of the entire region (25 kb) was obtained by analysing the large plasmid, pLC43-46, with four endonucleases. BamHI, EcoRI, HindIII and SaII (Fig. 1) . This map is consistent with previous results obtained with the ColEl plasmids and the A phages. Furthermore, by taking account of the known positions of the mop, amp and frd genes and by expressing genetic linkage data in kb according to Wu (1966) , a good correlation between the genetic and restriction maps was obtained (Fig. 1) . This indicates that the aspA is located very close to the mop genes in the melmop segment. During the course of isolating the aspA gene, several new plasmids were constructed and these are shown in Fig. 1 . They were all obtained by sub-cloning restriction fragments into appropriate sites in pBR322 or pBR325, and the sources of the bacterial fragments inserted into specific plasmids were: AGlF, 4.9 kb HindIII (pGS39); and pLC43-46, 5.4 kb BamHI-SalI (pGS67), 5.0 kb SalI-EcoRI (pGS71), 7.7 kb EcoRI (pGS72) and 12.5 kb SalI-Hind111 (pGS73).
The five newly constructed plasmids, plus pBR322 as a control, were tested for the presence of the aspA gene by transfoi-ming competent cultures of the aspA (JRG1113, JRG1114) and aspA recA(JRG1480, JRG1476) mutants and selecting independently for AmpR and Glt + phenotypes. Some 20 to 50 AmpR transformants and Glt+ transformants (plus revertants) were then tested for co-inheritance of the alternative phenotype by replica plating. Only one plasmid, pGS73, gave reproducibly high frequencies of AmpR Glt + cotransformation and it was concluded that the aspA gene is located in the 12.5 kb fragment of bacterial DNA cloned therein. In addition, the results suggest that the aspA gene contains, or is very close to, the EcoRI site in the 12.5 kb fragment, because there is no evidence for aspartase expression with the plasmids (pGS71 and pGS72) that contain the segments flanking this site. The results are entirely consistent with the location of the aspA gene predicted from genetic studies (Fig. 1) .
Further attempts to define the position of the aspA gene were made following a detailed analysis of pGS73 for restriction targets that could be used in sub-cloning. A map of pGS73 based on cleavage patterns obtained with different combinations of 17 restriction enzymes is shown in Fig. 2 . Some 29 sites were placed in the 12.5 kb SalI-Hind111 fragment of bacterial DNA and evidence for a further 13 sites, including several for HpaI, PuuII, PstI and BclI, was obtained. The relative orders of some of the very close sites were not defined unambiguously. No sites were detected for SstI and XhoI.
This analysis suggested that digestion with BclI would release a 2-8 kb fragment containing the EcoRI site, that had been predicted to be in or close to the aspA gene, flanked by 1.7 kb and 1.1 kb segments of bacterial DNA. Accordingly, this fragment was isolated from a BclI digest of Cloning of the E. coli aspartase gene 1275 pGS73 and sub-cloned into the BamHI site of pBR322 to generate plasmid pGS94 (Fig. 2) . The orientation of the sub-cloned fragment was deduced by restriction analysis with EcoRI and the positions of the AccI, AvaI and SphI sites in the fragment were confirmed by restriction analysis.
No plasmids with the fragment inserted in the opposite orientation were recovered. Plasmid pGS94 was tested for complementation of the aspA lesion, and, like pGS73, it gave reproducibly high frequencies of the AmpR Glt + cotransformation with the aspA and aspA recA strains. Thus it would appear that the 2.8 kb BclI fragment of pGS94 possesses a functional aspA gene.
Studies with 'maxicells'
The 'maxicell' technique was used to investigate the gene products expressed from pGS73 and pGS94 and a typical autoradiogram is shown in Fig. 3 . The polypeptides that appeared unique to pGS73 were classified as strongly expressed ( M , 61 000, 31 500, 21 000, 18000, 16000 and 11 000) and poorly expressed ( M , 56500,55000,51000, 36000, 33000,28500 and 27500). The coding capacity predicted for the bacterial insert of pGS73 would just be sufficient to encode these polypeptides if it is assumed that each labelled band represents a single polypeptide and if they are neither artefacts nor degradation products. By comparison, experiments with several independent isolates of pGS94 indicated that this plasmid encodes only one specific and relatively poorly expressed polypeptide, M, 55000 (Fig. 3) . No preferential labelling of a polypeptide of this size was ever detected with pBR322. The simplest but not the sole interpretation of these observations is that the polypeptide of M, 55000 is the product of the aspA gene. It is also likely that two of the strongly expressed polypeptides, M, 61 000 and 16000, correspond to the mopA (groEL) and mopB (groES) gene products, respectively. These have been identified previously as polypeptides of M , 65 000 and 15 000 (Tilly et al., 198 1) or M, 57 000 and 14000 (Neidhardt et al., 1983) . Several other products that are expressed from the 94 min region of the E. coli chromosome have been detected with pLC16-43 and pLC43-46 (Neidhardt et al., 1983) . Their sizes, derived from two-dimensional electrophoretic gel coordinates, are approximately, 35 000 (ampC), 27 000, 21 000 (two polypeptides), 13 000 and 1 1 700. Some of these may correspond to polypeptides detected with pGS73, because the fragment cloned in pGS73 is derived from pLC43-46.
Enzymological studies with plasmid-containing strains
The aspartase specific activities of plasmid-containing derivatives of several aspA strains were compared with the corresponding plasmid-free mutant and aspA + strains. Typical sets of results are shown in Table 2 . These were reproducible and it is clear that the aspartase activity is not only restored to the aspA mutants by pGS73 and pGS94, but amplified four-to sixfold relative to the corresponding aspA + parental strains. These observations are consistent with aspA being the aspartase structural gene and with its location in the segment of DNA common to both plasmids. 
DISCUSSION
The aspA gene of E. coli has been isolated in two derivatives of pBR322, pGS73 and pGS94, by sequential sub-cloning from a large ColEl-frd+ hybrid plasmid. The position of the gene fully supported the cloning strategy that was based on the gene location, predicted by correlating earlier genetic linkage data with a restriction map of the corresponding segment of bacterial DNA. The evidence supporting the successful isolation of the gene was based on the nutritional complementation of aspA mutants and the restoration and amplification of aspartase activity in plasmid-containing mutant strains. Earlier attempts to demonstrate the presence of the aspA gene in the ColEl-frd+ source plasmid (pLC43-46) had been equivocal due to several factors including the instability of the aspA mutation and the lack of a convenient selection for plasmid maintenance. However, most of the problems were overcome by transferring the DNA to pBR322 in order to exploit ampicillin-resistance for selective purposes. Earlier failures to isolate the aspA gene from the A gene banks could also be explained if the critical EcoRI target lies within the aspA coding region or a region that is essential for aspA expression, and if the corresponding Hind111 fragment (~1 2 . 5 kb) exceeds the capacity of the vector phages. The simplest interpretation of the results is that the aspA gene product is the polypeptide of M , 55000 which is encoded by both pGS73 and pGS94. However, this polypeptide is somewhat larger than has been found or predicted for the aspartase monomer (45000 to 48000) from studies with the isolated enzyme (Rudolph & Fromm, 1971; Suzuki et al., 1973) and the possibility that the polypeptide labelled with pGS94 represents the product of an aspA-tet fusion has not been excluded. This would mean that one of the other polypeptides labelled with pGS73 could correspond to the aspA gene product. In the present work, no direct evidence linking aspartase function with the M, 55000 product was obtained and it is conceivable that the aspA product may not have been detected in the 'maxicells', but the coding capacity of the smaller plasmid (pGS94) would limit the size of any further product to less than 30000. It should also be noted that the aspartase structural gene was originally defined in studies with a temperaturesensitive mutant CS8ASPts and although the mutations of CS8ASP23 and CS8ASPts were shown to be in the same region, there was no evidence to indicate whether they affected the same gene (Marcus & Halpern, 1969b) . Consequently there remains the formal possibility that the gene, isolated by virtue of its ability to complement the CSSASP23 lesion, need not necessarily be the aspartase structural gene but a regulatory gene, or some other gene that affects the expression of aspartase. Nevertheless, the simplest interpretation of the results is that the aspartase structural gene has been isolated and its product identified. Current studies aimed at defining the nucleotide sequence of the cloned gene will provide the primary structure of its product for comparison with the isolated aspartase protein. The aspartase gene appeared not to be strongly expressed and the degree of amplification in the plasmid-containing strains was modest (four-to sixfold). Studies on the regulation of aspartase synthesis should be facilitated by the isolation of the gene. Also, by coupling the gene to stronger promoters, it should be possible to obtain cultures that are highly enriched for aspartase and these could be important for the industrial production of L-aspartate, using immobilized cells (Nishida et al., 1979) .
